MDT - Medtronic plc

NYSE - NYSE Delayed Price. Currency in USD
92.16
+1.79 (+1.98%)
At close: 4:01PM EST
Stock chart is not supported by your current browser
Previous Close90.37
Open94.87
Bid0.00 x 2200
Ask0.00 x 800
Day's Range91.33 - 94.89
52 Week Range76.41 - 100.15
Volume8,270,822
Avg. Volume5,231,416
Market Cap124.463B
Beta (3Y Monthly)0.63
PE Ratio (TTM)39.74
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.00 (2.12%)
Ex-Dividend Date2018-09-27
1y Target EstN/A
Trade prices are not sourced from all markets
  • Thomson Reuters StreetEvents51 minutes ago

    Edited Transcript of MDT earnings conference call or presentation 20-Nov-18 1:00pm GMT

    Q2 2019 Medtronic PLC Earnings Call

  • Medtronic plc (MDT) Q2 2019 Earnings Conference Call Transcript
    Motley Fool11 hours ago

    Medtronic plc (MDT) Q2 2019 Earnings Conference Call Transcript

    MDT earnings call for the period ending October 31, 2018.

  • Medtronic (MDT) Tops Q2 Earnings on Strong Segmental Growth
    Zacks12 hours ago

    Medtronic (MDT) Tops Q2 Earnings on Strong Segmental Growth

    Medtronic (MDT) demonstrated improved performances at CER on growth in all business segments. However, costs continue to escalate.

  • Investing.com15 hours ago

    Medtronic Rises 4%

    Investing.com - Medtronic (NYSE:MDT) rose by 4.19% to trade at $94.16 by 09:30 (14:30 GMT) on Tuesday on the NYSE exchange.

  • Reuters16 hours ago

    Medtronic sets rosy outlook on strong cardiac, surgical product sales

    Medical device maker Medtronic Plc on Tuesday beat analysts' profit estimates for the second quarter and boosted its annual revenue growth outlook, driven by robust sales at its cardiac and surgical product units, sending its shares up 3 percent. Sales at the unit rose 26 percent helped by the strong adoption of MiniMed 670G system in the United States. Medtronic's MiniMed 670G "artificial pancreas" is the first device to automatically deliver the right dose of insulin to patients with type 1 diabetes.

  • Investing.com18 hours ago

    Medtronic Earnings, Revenue beat in Q2

    Investing.com - Medtronic (NYSE:MDT) reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.

  • Medtronic Moves a Step Ahead With Mazor Robotics Buyout
    Zacks18 hours ago

    Medtronic Moves a Step Ahead With Mazor Robotics Buyout

    Medtronic's (MDT) resolve to take over the Israel-based robotic surgical guidance systems company, Mazor Robotics, adheres to its goal to grow in the sphere of robotics spine surgery.

  • Medtronic (MDT) Tops Q2 Earnings and Revenue Estimates
    Zacks18 hours ago

    Medtronic (MDT) Tops Q2 Earnings and Revenue Estimates

    Medtronic (MDT) delivered earnings and revenue surprises of 7.02% and 1.77%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Benzinga18 hours ago

    The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 19) Merck & Co., Inc. (NYSE: MRK ) Down In The Dumps (Biotech ...

  • CNBC19 hours ago

    Stocks making the biggest move premarket: TGT, BBY, KSS, LOW, MDT & more

    Check out the companies making headlines before the bell: Target TGT – The retailer earned an adjusted $1.09 per share for the third quarter , 3 cents a share below estimates. Revenue exceeded forecasts, however, and comparable-store sales were up 5.

  • MarketWatch19 hours ago

    Medtronic reports Q2 profit, revenue beats

    Medtronic PLC reported second-quarter profit and revenue beats early Tuesday, but also said it has taken hits from foreign exchange rates and projected China tariffs. Company shares slumped 0.2% in premarket trade. Earnings for the latest quarter declined to $1.115 billion, or 82 cents per share, from $2.017 billion, or $1.48 per share in the year-earlier period. Adjusted earnings-per-share were $1.22, above the FactSet consensus of $1.15. Revenue rose to $7.481 billion from $7.050 billion, above the FactSet consensus of $7.348 billion. The company said that if exchange rates hold for the rest of the fiscal year, fiscal 2019 revenue would be negatively affected by roughly $420 million to $520 million. Medtronic also said that "operational outperformance" in the first half of fiscal year 2019 had allowed the company to absorb expenses like foreign exchange impacts and the projected impacts of China tariffs. It continues to expect fiscal year 2019 adjusted EPS of $5.10 to $5.15, compared with the FactSet consensus of $5.12. Medtronic shares have lifted 0.4% over the last three months, compared with a 5.8% decline in the S&P 500 and a 2.9% decline in the Dow Jones Industrial Average .

  • Should You Be Pleased About The CEO Pay At Medtronic plc’s (NYSE:MDT)
    Simply Wall St.20 hours ago

    Should You Be Pleased About The CEO Pay At Medtronic plc’s (NYSE:MDT)

    Omar Ishrak became the CEO of Medtronic plc (NYSE:MDT) in 2011. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at other big companies. After Read More...

  • Associated Press20 hours ago

    Medtronic: Fiscal 2Q Earnings Snapshot

    On a per-share basis, the Dublin-based company said it had net income of 82 cents. Earnings, adjusted for amortization costs and restructuring costs, came to $1.22 per share. The results surpassed Wall ...

  • Reuters20 hours ago

    Medtronic reports 6 pct rise in quarterly revenue

    Medical device maker Medtronic Plc reported a 6 percent rise in quarterly revenue on Tuesday, helped by higher sales in its cardiac and vascular business. Net income attributable to the company fell to ...

  • Investing.com2 days ago

    Medtronic Falls 3%

    Investing.com - Medtronic (NYSE:MDT) fell by 3.19% to trade at $90.71 by 11:51 (16:51 GMT) on Monday on the NYSE exchange.

  • Benzinga2 days ago

    Medtronic's Q2 Earnings Preview

    Medtronic, Inc. (NYSE: MDT ) announces its next round of earnings this Tuesday, Nov. 20. Here is Benzinga's everything-that-matters guide for the Q2 earnings announcement. Earnings and Revenue Based on ...

  • Will Diabetes Arm Aid Medtronic's (MDT) Q2 Earnings Again?
    Zacks2 days ago

    Will Diabetes Arm Aid Medtronic's (MDT) Q2 Earnings Again?

    Medtronic (MDT) gains traction from the U.S. launch of its Guardian Connect product. This enables the company to further capture a considerable share in the $1-billion standalone CGM market.

  • CNBC4 days ago

    Cramer's game plan: Focus on opportunity as market awaits Fed, China news

    The "Mad Money" host will be watching for include key housing data, as well as news on interest rates and a potential trade deal. CNBC's Jim Cramer will be seeking out "man-made" buying opportunities for investors in the short week before Thanksgiving Day. "Immediately, there were questions about ... the validity or the sincerity of both of these statements," Cramer noted, referencing his own concern about the Fed's lack of rigor in its policymaking.

  • Stanley Druckenmiller Sells Facebook, Buys PayPal in 3rd Quarter
    GuruFocus.com4 days ago

    Stanley Druckenmiller Sells Facebook, Buys PayPal in 3rd Quarter

    Tech enthusiast also ditches Netflix, Alibaba

  • Will Strong RTG Arm Shape Medtronic's (MDT) Q2 Earnings?
    Zacks5 days ago

    Will Strong RTG Arm Shape Medtronic's (MDT) Q2 Earnings?

    Medtronic (MDT) poised to gain on continued RTG business growth in Q2.

  • Here's What Will Shape Medtronic's (MDT) Fate in Q2 Earnings
    Zacks5 days ago

    Here's What Will Shape Medtronic's (MDT) Fate in Q2 Earnings

    Medtronic (MDT) is expected to maintain a decent market share in the core pacing banking, backed by the continued rollout of Micra Transcatheter Pacing System.

  • Is Medtronic (MDT) Stock Outpacing Its Medical Peers This Year?
    Zacks6 days ago

    Is Medtronic (MDT) Stock Outpacing Its Medical Peers This Year?

    Is (MDT) Outperforming Other Medical Stocks This Year?

  • Medtronic (MDT) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks8 days ago

    Medtronic (MDT) Reports Next Week: Wall Street Expects Earnings Growth

    Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Mazor Robotics Marks Time as It Waits to Be Acquired
    Motley Fool9 days ago

    Mazor Robotics Marks Time as It Waits to Be Acquired

    The company's financial statements took a big step back during the quarter, but all eyes are on the pending Medtronic buyout.

  • GuruFocus.com12 days ago

    Jeff Auxier Comments on Medtronic

    Guru stock highlight